{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:38:35Z","timestamp":1771954715782,"version":"3.50.1"},"reference-count":54,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T00:00:00Z","timestamp":1270684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Aim:\u2003<\/jats:bold> Peroxisome proliferator\u2010activated receptor gamma (PPAR\u03b3) is generally accepted as renoprotective factor in type 2 diabetes mellitus, and PPAR\u03b3 agonists have been reported to reduce albuminuria. However, little is known about renal PPAR\u03b3 expression in chronic kidney disease, and especially human data are scarce. We hypothesized that renal PPAR\u03b3 expression is associated with extent of proteinuria, kidney function, histological diagnosis and inflammatory mediators. Therefore, we investigated PPAR\u03b3 mRNA expression in human kidney biopsies.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> We quantified PPAR\u03b3 mRNA as well as the expression of macrophage chemoattractant protein\u20101, transforming growth factor beta\u20101 and interleukin\u20106 in 64 human kidney biopsies from patients with chronic kidney disease and mild\u2010to\u2010marked proteinuria of diverse aetiology. We measured renal function, and macrophage invasion was quantified by CD68 and vascularization by CD34 immunostaining.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> PPAR\u03b3 mRNA expression correlated inversely with renal function. Higher blood pressure levels were associated with higher PPAR\u03b3 expression levels. PPAR\u03b3 mRNA expression correlated significantly (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) with macrophage chemoattractant protein\u20101 mRNA expression and showed a negative trend with transforming growth factor beta\u20101 mRNA expression. No differences in PPAR\u03b3 expression were detected with regard to extent of proteinuria, histological diagnosis, macrophage invasion, interleukin\u20106 expression, and age or body mass index.<\/jats:p><jats:p><jats:bold>Conclusions:\u2003<\/jats:bold> PPAR\u03b3 expression increases with loss of renal function and may be an important factor in maintaining normal renal function serving as a key protective mechanism to renal injury.<\/jats:p>","DOI":"10.1111\/j.1440-1797.2010.01339.x","type":"journal-article","created":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T04:44:19Z","timestamp":1270701859000},"page":"683-691","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Renal PPAR\u03b3 mRNA expression increases with impairment of renal function in patients with chronic kidney disease"],"prefix":"10.1111","volume":"15","author":[{"given":"JULIA","family":"LEPENIES","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARTIN","family":"HEWISON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAUL M","family":"STEWART","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARCUS","family":"QUINKLER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,8]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.11.026"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000102594"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1997.273.6.F1013"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00624.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1999.277.6.F966"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.03.012"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/34184"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590051899.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.02.068"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.8.1326"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000336"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002557"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002516"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1285"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1081\/ERC-120016822"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.539122"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00001.2002"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00411.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-10-199511150-00003"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11445-8"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02134"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001620"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.2.722"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00288.2005"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00152.2007"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2007.00903.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi172"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00476.x"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00445.2003"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn157"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1159\/000105125"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008111138"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.6.1022"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00097.2005"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002248"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl766"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2008.15"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00151.x"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/147323000703500407"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.05.061"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2007.00878.x"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4709"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00574.x"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.097519"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28859"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001444"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381303"},{"key":"e_1_2_7_51_2","first-page":"E989","article-title":"Antihypertensive and vasculo\u2010 and renoprotective effects of pioglitazone in genetically obese diabetic rats","volume":"272","author":"Yoshimoto T","year":"1997","journal-title":"Am. J. Physiol."},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000116303.71408.c2"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1278"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.256"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072761"}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1797.2010.01339.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1797.2010.01339.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T10:19:52Z","timestamp":1697278792000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1797.2010.01339.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,8]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1440-1797.2010.01339.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1797.2010.01339.x","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,8]]},"assertion":[{"value":"2010-04-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}